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Abstract 
 
Objectives:  Although research evidence exists to suggest why consumers use CAM, 
there remains a need to distinguish between factors and processes involved in the initial 
uptake of therapies and those involved in their subsequent maintenance.  We therefore 
conducted a qualitative study to explore and describe consumers’ reasons for maintaining 
or stopping CAM use.   
 
Methods:  This was a qualitative study.  We interviewed 46 CAM consumers and 9 CAM 
practitioners, in two high-street CAM clinics in the UK.  The interviews were analysed 
thematically using techniques from grounded theory.   
 
Results:  Consumers described and evaluated their CAM experiences along four 
dimensions: interpersonal (e.g. interactions with practitioners), physical (e.g. sensations 
such as touch or pain during treatment), affective (e.g. empowerment) and cognitive (e.g. 
beliefs about treatment).  They evaluated their experiences in relation to their individual 
needs and expectations; financial considerations could limit maintenance of CAM use.  
Practitioners emphasised the effectiveness of treatment and themselves as contributing to 
consumers maintaining treatment, and recognised the role of financial considerations in 
decisions to stop CAM use.   
 
Conclusions:  This study suggests that experiences of conventional medicine are of 
limited importance after the decision to initiate CAM.  Experiences of CAM were 
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foremost in our consumers’ decisions to maintain or stop specific CAM therapies.  
Maintenance of CAM could occur even if consumers’ experiences were not entirely 
positive.  Our findings provide novel, systematic, insights that will be of particular 
interest to practitioners who want to support consumers as they decide whether to 
maintain CAM use.
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Complementary and alternative medicine (CAM) includes a range of diverse therapies 
that are not commonly available through conventional medicine outlets nor commonly 
taught in conventional medical schools,1 and epidemiological surveys suggest that CAM 
use is common amongst the general population.2-9  Large-scale surveys provide a picture 
of the socio-demographic and clinical characteristics of CAM users, and the typical 
person who uses CAM is a well-educated woman of middle-age.3;5-7;10-13  CAM is used in 
relation to both general well-being and a range of specific, often chronic, illnesses.5;14-19  
Our understanding of why people use CAM rests on a growing number of predominantly 
small scale studies which have investigated the health beliefs and other psychological 
characteristics of CAM users (often compared to non-users) and the reasons that they 
themselves give for using CAM.  These studies support the suggestion that people are 
both attracted to CAM and deterred by conventional medicine.20  Pull factors that 
encourage people to use CAM include a holistic orientation to health, illness, and 
treatment;14;21-24 a desire to take an active role in treatment and/or develop an ongoing 
relationship with a caring practitioner;25-27 a desire to experience ‘natural’ therapies 
which are believed to have few if any adverse side-effects.25;28-30  People who use CAM 
may also hold less conventional philosophies in general14;31;32 and may be more likely to 
have certain personality characteristics, such as openness to experience.33;34  Push factors 
that deter people from using conventional medicine and thus contribute to CAM use 
include:  dissatisfaction with the quality of the doctor-patient relationship; 23;35;36 
experiencing (or belief that one will experience) adverse side-effects from conventional 
medicine;37-39 dissatisfaction with a lack of perceived or potential efficacy of 
conventional interventions.22;27;40   
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In an early review of the literature on CAM use, Siahpush highlighted the need to 
distinguish between factors that might be associated with the initiation of CAM use and 
those that might be more relevant to understanding its maintenance.41  A few cross-
sectional quantitative studies suggest differences between new and established CAM 
users,42;43 those with high and low commitment to CAM,44;45 and between those who rely 
on CAM and those who use it alongside conventional medicine.14  Adherence to CAM 
might be associated with patients’ experiences of a therapy,46 and their perceptions of 
their practitioner47 and illness.48  Men with prostate cancer were more likely to stop using 
CAM when a high degree of effort was required to maintain use.49  In qualitative studies, 
people who use CAM report benefiting from and highly valuing the relationship with 
their practitioner.50-55  Some qualitative work also suggests that the benefits experienced 
from CAM can encourage further CAM use, while the financial cost of CAM and a 
perceived lack of effectiveness can limit it.51;56-60  Yardley and colleagues61 showed how 
patients’ perceptions of chiropractic are shaped through dynamic interactions between 
concrete experiences (of symptomatic relief and commentary from their practitioner) and 
abstract beliefs (about treatment and illness).  Finally, models of CAM use in cancer 
illustrate the iterative and dynamic nature of CAM decision-making, and show how 
patients’ decisions to start, continue, and stop using CAM are closely entwined with the 
cancer trajectory.62-66  In summary, factors that might be involved in the maintenance of 
CAM use have been identified, but few of these studies have focused exclusively on 
consumers’ decisions to maintain or stop CAM use, and so this is an area that requires 
further study across different settings.  Such work is important not only to further our 
conceptual understandings of CAM use but also to provide systematic, evidence-based 
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knowledge to inform those individuals (e.g. CAM practitioners and providers) who might 
support consumers as they make decisions about using CAM. 
In the UK, CAM is used predominantly in the private sector,5 and CAM clinics 
are now commonly seen in town and city centre high streets and shopping centres.  Such 
visible and comparatively accessible clinics (in terms of cost and location) might 
represent an important aspect of the future of CAM provision, potentially widening 
access to CAM amongst the community and placing it firmly in a consumerist setting.  It 
thus constitutes a valid and indeed valuable setting for research into CAM use 
behaviours.  In this study we refer to people who use CAM as ‘consumers’, and this 
reflects the setting for our research.  The aim of our study was to explore why CAM 
consumers decide to maintain or stop CAM use.   
 
Methods 
 
Setting 
Field work was conducted in two high-street CAM clinics (in southern England), which 
had been established for approximately 18 months and were run by and located within the 
premises of a high street company primarily known for being a pharmacy, which also 
retails a range of other products, including beauty and personal hygiene products.  The 
clinics offered a range of therapies:  aromatherapy massage, herbalism, homeopathy, 
osteopathy and reflexology.  The company that owned the clinics co-funded this study, 
but had no role in its methodological design or analysis, or the decision to publish this 
paper.  The decision to conduct the study in these clinics emerged from negotiations 
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with the funders and an agreement to develop knowledge that would be directly relevant 
to the company.  The clinics provided a valuable context because a) they were highly 
accessible and visible to people who might not otherwise have considered CAM use – 
they thus represented an arena which had the potential to widen access to CAM and to 
bring it into a consumerist setting, and b) they offered a range of CAM therapies allowing 
us the potential to generate findings that applied to more than one therapeutic modality.   
 
Ethical Issues 
Ethical approval was granted by the School of Psychology, University of Southampton, 
Ethics Committee.  Ethical issues can be complex when field work is undertaken for a 
prolonged period of time and the researcher becomes a trusted and accepted member of a 
setting.  Before commencing fieldwork the researcher met with all practitioners to discuss 
the project and to seek informed consent.  Her identity in the setting was as a student 
interested in complementary medicines, and she reinforced her identity as an independent 
researcher by wearing a University identity card and not wearing the clinic uniform. 
 
Data Generation and Collection 
The researcher spent a period of three months in the two clinics, attending the clinics on 
week days and week-ends to gain access to the range of people attending for different 
therapies.  This ethnographic field-work included the collection of different forms of data 
(e.g. documents, photographs) in order to allow a rich multi-faceted account of CAM use 
to be developed and to enable more focused research questions to emerge, such as the one 
addressed here.  The present analysis focuses on the interview data as this is most 
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relevant to understanding, from consumers’ perspectives, why CAM consumers decide to 
maintain or stop CAM use.  Consistent with the ethnographic approach to the field-work, 
interviews were conducted in a range of styles including semi-structured, informal, and 
unstructured.  Consumers were invited to take part in an interview by either their 
practitioner or the researcher, who approached them either before or after their 
appointment.  Decisions about who to interview were guided by the principal of 
maximum variation sampling.  Attempts were made to interview, for example, consumers 
using different therapies (because we anticipated that people attending different therapies 
might emphasise different aspects of experience, all of which needed to be incorporated 
into any comprehensive model) and consumers who were new or returning for follow-up 
appointments were interviewed (because ‘new’ consumers would be well-placed to tell us 
about early decisions to maintain or stop CAM while those who were returning for 
follow-ups would be able to tell use both about the consequences of such early decisions 
and any subsequent decisions and experiences).  Interviews were carried out with 46 
consumers (42 women and 4 men) and 9 practitioners.  The consumers were attending the 
clinics for aromatherapy massage (12 people), herbalism (3 people), homeopathy (8 
people), osteopathy (13 people), or reflexology (12 people).  Twenty five interviews were 
carried out after a consumer’s initial appointment for a therapy, and twenty three 
interviews were carried out after follow-up appointments.  Five people were interviewed 
twice in order to provide some insights into individuals’ journeys as they went from 
‘new’ to ‘returning’ visitors to the clinics.  These interviews thus provided a longitudinal 
perspective that acted as a check on our otherwise ‘snapshot’ approach.  Audio-tapes and 
notes were used to record interviews wherever possible; if participants did not want to 
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be recorded notes were made during and immediately after interviews.  Consumers were 
invited to take part in interviews either by their practitioner or by the researcher.  All 
participants were allocated, or chose their own, pseudonyms to protect their anonymity. 
 
Data Analysis 
Audiotapes were transcribed verbatim (and transcriptions reviewed for accuracy) and 
field notes were typed up both during and immediately following the field-work.  Atlas.ti 
was used to facilitate data organisation, management and analysis.  The analysis began 
during the field work, when initial impressions of both potential themes and the direction 
of the research were noted.  Following the field work and a period of data immersion, the 
textual data were first analysed using inductive, open coding including in vivo codes.  At 
this stage each line of every text was annotated with a code.  Similar codes were then 
merged to develop categories, which were refined by comparing different categories with 
each other and comparing different instances of the same categories (both across and 
within participants).  This analytic method, the constant comparative technique, was 
drawn from Strauss and Corbin’s version of grounded theory.67  As the analysis 
progressed other techniques were also employed, including axial coding (where coding 
focuses on a smaller number of higher level categories, seeking to detail their 
characteristics) and deviant case analysis (where attempts are made to seek out instances 
in the data that are inconsistent with the emerging analysis).  In the final stages of 
analysis the aim was to develop process-oriented themes that answered the analytic 
question ‘what is happening here’.  Three main process-oriented themes were developed 
which could explain the bulk of the data and provide insights into consumers’ 
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behaviour.  These themes were labelled Finding a Therapy, Finding a Practitioner, and 
Experiencing and Evaluating CAM.  This paper reports on the latter theme, Experiencing 
and Evaluating CAM, and considers both practitioners’ and consumers’ experiences.  In 
relation to consumers, the findings are organised around the three main consequences of 
experiencing and evaluating CAM:  maintaining CAM use, returning to CAM, and 
stopping CAM use.  Quotations have been selected to present typical illustrations of 
participants’ talk.  A separate analysis of this data focussed on how patients conceptualise 
CAM therapies and has been reported previously 68. 
 
Findings 
 
CAM Practitioners 
Practitioners’ talk about why they thought people came back to see them was 
characterised by two themes - the impact of the treatment itself on their patients and the 
practitioners themselves as important factors in the maintenance of CAM use.  For 
example, Sally said that her patients come back because ‘the treatment's working and 
they can see that. Hopefully me.’  In comparison why people stop CAM use was more 
mysterious for the practitioners.  John said that:  ‘People don't turn up for the follow up 
and then pop up again six months or even years later, saying that you helped them before 
and they've got a new problem.’  Practitioners felt that financial cost could prevent the 
maintenance of CAM use, but they perceived that they had no say in the amount of 
money charged for their therapy in the clinic and so felt as if they had little control over 
the business side of CAM provision.   
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Paula:  If it was vouchers or a present or they can’t really afford it that’s probably 
the last time I see them until their next birthday.  And the people like old aged 
pensioners they’re not getting paid so it’s quite a lot of money for them and very 
often they would love to come back […] that’s a bit frustrating […] there’s 
nothing that I can do about it. 
 
CAM Consumers 
Four sub-themes were identified that reflected the main dimensions of consumers’ 
experiences of treatment.  The interpersonal dimension of experience reflects the 
relationship that consumers had with their practitioner and the communication that 
occurred between them.  The physical dimension of experience comprises the sensations 
that consumers experienced during treatment or thought resulted from treatment, such as 
touch or pain.  The affective dimension incorporates the more emotional aspects of 
treatment experiences, such as feeling empowered, happy or re-assured.  Finally the 
cognitive dimension reflects aspects of the treatment experience that occur on a more 
abstract level (e.g. attitudes, beliefs) and can also include changes in cognitions that result 
from treatment (e.g. gaining new knowledge about a treatment).  In describing these 
different dimensions of experience, CAM consumers also evaluated their experiences in 
relation to their individual needs and expectations (see Box).  Practical considerations 
also featured in consumers’ talk about maintaining and stopping CAM use.   
 
CAM Consumers:  Maintaining CAM use. 
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CAM consumers who had been seeing their practitioner for more than six months 
evaluated their treatment positively.  They provide clear examples of how the different 
dimensions of experience feed into decisions to maintain CAM use.  Theresa had been 
seeing the homeopath for 18 months, and both the physical impact of homeopathy and 
her trust in the homeopath (Ian) appeared to contribute to her maintaining her CAM use:  
‘I was very impressed when I met Ian and realised he knew what he was talking about, 
and he’s helped me no end.’  Experiences did not have to be exclusively positive in order 
for CAM use to be maintained.  The experience of taking her remedies had not always 
been pleasant, but Theresa continued to use them because she found them effective, and 
less unpleasant than the conventional equivalent. 
 
Theresa:  The drops for the blood pressure […] they’re absolutely disgusting but 
it’s brought my blood pressure down so they say the nastiest medicines are best 
don’t they […] And better to have a disgusting flavour first thing in the morning 
than swollen legs and breathlessness and all that sort of thing […] from the other 
medication 
 
Kay had seen the homeopath twice, and talked about her extensive experience of also 
using osteopathy and chiropractic in the past.  She summed up her ongoing use of CAM 
forms and the importance of previous experience when she said ‘The proof was in the 
eating.’  She went on to explain that the affective dimension of experiencing CAM 
treatments through the therapeutic relationship also plays an important role in 
maintaining her CAM use. 
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Kay:  It worked [chiropractic/osteopathy], I walked out and so you keep going. 
My experiences as a child with eczema [with homeopathy] I think had the biggest 
impact on my use of alternative health. Also, I feel more in control with 
alternative medicine that I do with a GP. I've only ever found one GP that does 
this shift in power or control. It really makes a difference - coming out feeling 
you're doing something positive. 
 
Some CAM consumers who were interviewed had seen their practitioner only once and 
had little previous experience of CAM.  The idea that it is too soon to pass judgement on 
whether a therapy ‘works’ was characteristic of such consumers.  However, again these 
consumers described experiences across all four dimensions identified above.  Betty was 
interviewed after her first ever reflexology appointment, which surpassed her 
expectations and had an immediate physical impact on her, as well as leading to a 
cognitive shift in her understanding of reflexology.   
 
Betty:  Well I didn't appreciate the treatment basis of it, not until I actually had it. 
I thought it would just be quite nice and relaxing. I was amazed at how it helped 
my feet, they feel so much better already. And I've got other problems as well, 
back pain, and I'm not sleeping very well at all […] And she Lara [the 
reflexologist] can pick all that up through your feet. Lara was explaining it all to 
me. My feet feel wonderful now. They're quite painful most of the time, even 
sitting down, especially when I've been at work all day. I've got no pain now 
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though, all I can say is wow! 
 
Betty was asked whether she thought she would come back for another reflexology 
appointment, and despite her positive experience she did not commit herself to a 
judgement on reflexology:  ‘I'm still going to stay a bit sceptic though. I need more 
appointments and see what happens, then I'll know if it really is good.’  When further 
prompted about what she would base this judgement on, Betty focused on the immediate 
and direct physical benefit to her feet that she has found from reflexology.  By focusing 
on this, Betty could avoid taking on board the principles underlying reflexology, and she 
could talk of reflexology as a foot massage, retaining her scepticism regarding the 
theoretical framework of reflexology as a form of health care.   
 
Betty:  Well I think it is worth it just for my feet. The other stuff would be an 
extra benefit. I just think that if it can help with all the other things, then why 
don't doctors and hospitals use it?  
 
Other participants also experienced some physical impact of their treatment and decided 
to come back and ‘give it a chance’.  This process could be shaped by their interpretation 
of what their practitioner had told them during their first consultation (i.e. the 
interpersonal dimension).  Jasmina was interviewed when she came into the clinic to pick 
up a repeat prescription from the herbalist, having had one consultation and taken the 
prescribed herbal preparation for one month.  Jasmina thought that the herbs had had 
some effect on her, but was unsure exactly what effect or how the herbs worked. 
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Jasmina: It was quite strange when I first took it um I could feel things like a 
funny sensation in my stomach so I knew it was doing something […] maybe it’s 
mind over matter or something I don’t know but it seems to have um helped my 
periods this time round. 
 
Later on in the interview Jasmina said that ‘it seems to have done something to me but 
um obviously it’s too soon to know one way or another.’  When asked how long she 
intended continue with herbalism, she drew on advice from the herbalist: ‘Julie said it 
must be about three months before I can know so I think I’ll give it ‘til then.’  Thus the 
physical and interpersonal dimensions of treatment appear to have contributed to 
Jasmina’s evaluation and decision to maintain her use of herbalism.  The herbalist 
provided a timeframe within which Jasmina could continue experiencing and evaluating 
her treatment.  Such timeframes also provided consumers with a guide to likely financial 
cost of maintaining CAM use.   
 
Linda: Yes, she said to come back in two weeks and see how it’s going but that 
should be it  
I: That’s nice and quick  
Linda: Yes, some people take you for a ride a bit keep you going for three months 
and it costs a fortune, so now I’m quite happy with Sally [osteopath] doing my 
neck today it’s much gentler and I feel better now even [...].  It’s very difficult to 
say at this stage if it’s going to get better or not.  After two sessions you can’t 
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really know what the outcome’s going to be, but she seems pleased with what 
she’s done and she does know what she’s doing but I’ll have to wait and see  
I: Ok and why did you come back today then 
Linda: Because at the start she said I would need more than one session and then 
she said she’d say today how many more I needed, and that most people don’t 
need more than five, so I was happy to come back today give it a chance 
 
Returning to CAM 
Returning to CAM emerged as a distinct form of maintaining CAM use, in which 
consumers returned for a new episode of treatment to a form of CAM they had used 
previously.  CAM consumers who did this explained their current use of a therapy by 
talking about how it had successfully met their needs previously and how, based on their 
past experience and current problems, they expected it to meet their current needs.  
Consumers also reported returning to CAM because they experienced a specific physical 
problem, they wanted to improve their general wellbeing, or they believed that the 
particular CAM was consistent with their health beliefs.  For example, Abby returned to 
osteopathy for a recurring back and neck problem.   
 
Abby: Well because I’ve got neck and back trouble that I’ve had for quite some 
years anyway so I’ve been to osteopaths before […] I think me I’m one of those 
people that I tend to adjust to things so if my neck hurt I stop doing whatever it 
was and you suddenly realise I’ve been putting up with this and this is ridiculous 
why don’t I just go and get it sorted.   
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Interestingly, past experience of a CAM did not have to be successful to encourage 
consumers to return.  Kay constituted an extreme example of this in that she had 
previously tried homeopathy but it had made her symptoms worse and she felt unable to 
stick to the treatment because she was starting a new job at the time.  This experience did 
not put her off using homeopathy and in the following quotation she talks explicitly about 
how she returned to homeopathy because she believed it was more appropriate (than 
conventional medicine) given the nature of her symptoms and her preference for holistic 
interventions.   
 
Kay:  This time, I've got more of a general feeling that my body is not functioning 
properly. You can't go to your GP for this. Also I'm conscious of the time 
pressure on GPs. They look for specific causes and it could be a whole series of 
things and it would take ages to find it. I believe in homeopathic. It’s convenient 
and affordable and you get a good service at [clinic]. Also, when you have 
general malaise homeopathy is better, it is a general, holistic approach. I think as 
well with my family history, the problems my mother and father have had, I want 
to prevent similar problems. I can't go to my GP for that, but homeopathy takes it 
into account.   
 
CAM Consumers:  Stopping CAM Use 
A number of participants reported treatment episodes at other clinics which they 
evaluated negatively and so did not continue.  Again, all four dimensions of experience 
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were apparent in decisions to stop CAM use, as were practical considerations.  While 
Helen found some aspects of acupuncture positive, it did not meet her expectations and 
was expensive:  ‘It was relaxing and I enjoyed it but I didn't lose weight and it was too 
expensive really.’  A combination of experiencing physical side-effects from a Chinese 
herbal remedy and feeling as if she was forced into her treatment by the practitioner led 
Clair to stop using Traditional Chinese Medicine (TCM).   
 
Clair:  I tried TCM once, but I got bad effects from the herbs and he refused to 
change them. […] I did not go to the third one [appointment], even though I'd 
paid for it I didn't want to go. There's an issue of trust with TCM. 
 
Some interviewees who evaluated their treatment at the clinic positively said that the 
financial cost would put a limit on their ongoing use. For example, Freya says that 
reflexology ‘could be cheaper. I don't come very often.’  However, few participants 
evaluated their treatment at the clinic in negative terms and said they were unlikely to use 
the treatment again.  Those who did had been bought their appointments as gifts.  While 
Max enjoyed his reflexology appointment and found it relaxing, he thought it was too 
expensive for him to use again.   
 
Max: [laughs] I’ve just paid the bill not at forty five quid [laughter] so no  
I: Ok if it didn’t cost so much  
Max: Oh sure for a nice foot massage I wouldn’t be coming back cos I thought it 
was any good for me but it was very nice. 
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CAM consumers also described stopping an episode of treatment because they 
considered it to have been successful.  In these cases, participants were very positive 
about possible future use of the treatment.  Robby thought his first ever experience of 
osteopathy was very successful, and on the basis of this success (and his view of 
osteopathy as more appropriate for back problems than seeing his GP) he would use 
osteopathy again.  
 
Robby:  Tim explained didn’t get too technical, explained what he felt had 
happened. […]  It was a very thorough examination and his treatment really 
targeted the area […] I certainly feel better.  Whether that’s psychosomatic or not 
I don’t know but I feel more reassured if you like. […]  Tim or his colleagues 
would have to know the structures of the bone, how they interact, what is right, 
what is wrong within the body so that they can detect any potential errors.  And in 
that sense […] if I have a joint or back problem I would rather talk to say Tim 
because I feel his examination would be better than a GP who is more likely to 
talk to me about what is happening, prescribe some anti- inflammatory drugs and 
tell me to go away and if in two weeks time it’s not any better come back and see 
me […]. 
 
Discussion 
The CAM consumers that we interviewed described maintaining their CAM use based on 
positive evaluations of (at least) one of four dimensions of treatment - physical, affective, 
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cognitive and interpersonal.  While positive evaluations were typical, it is important to 
note that CAM use could be maintained despite negative evaluations of some aspect of 
treatment (e.g. taste).  The interpersonal dimension of treatment appeared to be 
particularly important early in treatment.  According to CAM consumers, practitioners 
helped to encourage their maintenance of CAM use early in treatment by providing them 
with a timeframe within which they might expect to experience benefit(s).  Our analysis 
suggests that the processes and factors involved in maintaining CAM use are slightly 
different to those involved in CAM use in general: maintaining CAM use appears to be 
more dependent on positive experiences of CAM (pull factors) than on negative 
experiences of conventional medicine (push factors).  This is consistent with some 
previous research43;47 (but not all51).  Our interviewees described stopping CAM use, if 
either a) it had successfully resolved an acute problem, or b) it had failed to meet their 
expectations and/or provide desired health benefits, and/or they felt it was too expensive.  
The CAM practitioners who we interviewed also talked about how the physical 
effectiveness of CAM and their skills as practitioners can encourage maintenance, and 
the role of financial considerations in decisions to stop using CAM. 
The field-work from which this analysis was derived was situated within one 
particular therapeutic setting and focussed on two clinics.  This approach facilitated an in-
depth study of the initiation and maintenance of CAM use in this consumerist setting, but 
could leave the transferability of the findings to other settings questionable.  In particular 
ongoing CAM use in a publicly funded setting (e.g. the NHS) might be quite different 
from ongoing CAM use in the private sector.  The similar location of the two clinics also 
limits the extent to which we would want to transfer our findings for example to inner-
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city settings or CAM users in other countries.  Furthermore, there are likely to be 
additional illness-specific factors that can be involved in the decision-making process that 
will not have been identified in this study of CAM use in a diverse group of people.  This 
work may also be limited by a reliance on one-off interviews with participants (although 
five were interviewed twice and interviewees ranged from first-time CAM users to 
experienced, committed users).  The role of the company in co-funding the research 
could have influenced the practitioners’ disclosures during the interviews; to mitigate 
against this the interviewer emphasised the intellectual independence of herself and her 
research from the clinic and re-assured the practitioners that their interviews would not be 
made available to the company, and that any verbatim quotes used in publications would 
be anonymised. 
Commonalities between our work and existing studies support the credibility of 
our findings and suggest that at least on an abstract level our findings might be 
transferable to other CAM treatments if not settings.  Others have described the 
experience of CAM treatments as multidimensional, for example Luff and Thomas 51 
highlighted the physical and psychological dimensions.  Yardley et al 61 emphasised the 
importance of the interpersonal dimension in their discussion of chiropractors’ online 
commentaries, which they explained might shape patients’ perceptions of and adherence 
to their treatment through providing explanations linking treatment approach, illness 
perceptions, and likely outcomes.  The role of financial considerations and perceived lack 
of benefit have previously been identified as contributing to stopping using CAM, and 
perceived benefits have previously been shown to encourage ongoing CAM use.51;56-60   
This study adds to the understanding of the processes involved in CAM use by 
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specifying and describing the different dimensions of experience that patients consider 
when maintaining or stopping CAM, and by focusing on an emerging setting for CAM 
consumption – the high street clinic.  Keeping in mind the caution required in terms of 
the transferability of the analysis (which should be tested in future work), the findings 
from this study have a number of implications for research and CAM provision.  Peoples’ 
experiences of treatments were analysed as belonging to four dimensions, physical, 
affective, cognitive and interpersonal.  This is relevant to the question of what 
mechanisms underlie experiences of CAM, and suggests that researchers need to attend 
to a range of possible levels of experience and to develop sophisticated methodologies in 
order to do this.  It also highlights a limitation in scope of existing quantitative work on 
CAM use.  Questionnaire-based studies (including those by the authors) primarily assess 
peoples’ interpersonal and, to an extent, physical experiences of therapy, but rarely 
evaluate their affective or cognitive experiences.  This study highlights the broadness of 
CAM as an experience and the need to develop appropriate tools to quantitatively 
evaluate the whole range of dimensions of experiences of CAM.  Both the close 
relationship between different dimensions of peoples’ experiences and the shear range of 
experiences also has implications for research into CAM outcomes, providing further 
evidence that patient-centred outcome measures such as the MYMOP 69 might be more 
appropriate than generic outcome measures that focus on a narrow range of primarily 
physical experiences.  The finding that participants were often unwilling to commit 
themselves to an evaluation of treatment (citing the importance of trying something out 
or waiting to see what happens) also highlights that the timing of any self report measures 
related to appraisal of treatment requires further theorising and empirical study.  In 
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relation to practice, perhaps the most encouraging finding is that practitioners appear to 
have an important role to play in their patients’ decisions about whether or not to 
continue with treatment.  According to our sample of CAM consumers, providing a 
timeframe early in treatment can encourage them to postpone any premature judgements 
of effectiveness.  Our findings might usefully inform CAM practitioners as they work 
both to support consumers in making decisions about CAM use and also to decrease 
barriers for those consumers who wish to maintain CAM use.  However any specific 
recommendations for practice based on this single qualitative study would themselves be 
premature, and further research is needed to determine effective and ethical means to 
support consumers as they make decisions to maintain or stop CAM use. 
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